drugset / Trial / NCT04807621

Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery

NCT04807621

Phase 2 Unknown 40 enrolled Sahlgrenska University Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The study aims to test whether platelet transfusion or fibrinogen concentrate is the most effective treatment of intraoperative bleeding, when performing open heart surgery with cardiopulmonary bypass on children with congenital heart defects.

Timeline

Start
2018-03-14
Primary completion
2022-01
Completion
2022-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic 300 mg/kg
Comparator Platelet transfusion Unknown 10 unknown Other